Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study

BACKGROUND: Drug-induced liver injury (DILI) is a common complication of tuberculosis treatment. We utilised data from the REMoxTB clinical trial to describe the incidence of predisposing factors and the natural history in patients with liver enzyme levels elevated in response to tuberculosis treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Tweed, Conor Duncan, Wills, Genevieve Helen, Crook, Angela M., Dawson, Rodney, Diacon, Andreas H., Louw, Cheryl E., McHugh, Timothy D., Mendel, Carl, Meredith, Sarah, Mohapi, Lerato, Murphy, Michael E., Murray, Stephen, Murthy, Sara, Nunn, Andrew J., Phillips, Patrick P. J., Singh, Kasha, Spigelman, M., Gillespie, S. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875008/
https://www.ncbi.nlm.nih.gov/pubmed/29592805
http://dx.doi.org/10.1186/s12916-018-1033-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875008/
https://www.ncbi.nlm.nih.gov/pubmed/29592805
http://dx.doi.org/10.1186/s12916-018-1033-7

Ejemplares similares